β2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity

Respiratory Medicine

Volumn 93, Issue 6, 1999, Pages 416-423

  Silvestri, M ^a   Oddera, S ^a   Lantero, S ^a   Rossi, G A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD11B ANTIGEN; COMPLEMENT COMPONENT C5A; FENOTEROL; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIGEN EXPRESSION; ARTICLE; BRONCHUS MUSCLE; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; INTRACELLULAR KILLING; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 0033023057     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.1999.0584     Document Type: Article

References (41)

1. Thompson AB, Daughton D , Robbins GA, Ghaufouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140: 1527-1537.
2. Snider GC. Chronic bronchitis and emphysema. In: Murrey JF, Nadel JA (eds) Textbook of Respiratory Medicine. Philadelphia: WB Saunders, 1988: 1069-1106.
3. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.
4. Hogg JC. Neutrophil traffic. In: Crystal RG, West JB (eds) The Lung, Vol. 1. New York, NY: Raven Press 1991: 565-579.
5. Junod AF. Neutrophils, oxidants and tissue damage. In: Pozzi E (ed.) Neutrophils, Lymphocytes and Lung. Milan: Masson, 1990: 49.
6. Travis J. Neutrophil enzimes and emphysema. In: Pozzi E (ed.) Neutrophils, Lymphocytes and Lung. Milan: Masson, 1990: 49.
7. McElvaney NG, Crystal RG. Proteases and lung injury. In: Crystal RG, West JB (eds) The Lung, Vol. 2. New York, NY: Raven Press: 1991: 2205-2218.
8. Stockley RA. Proteolytic enzymes, their inhibitors and lung diseases. Clin Sci 1983; 64: 119-126.
9. Wright DG. The neutrophil as a secretory organ of host defence. In: Gallin J, Fauci AS (eds) Phagocytic Cells: Advances in Host Defence Mechanisms, Vol. 1. New York, NY: Raven Press 1982: 75-110.
10. Balbi B, Aufiero A, Pesci A, Oddera S, Zanon P, Rossi GA, Olivieri D. Evaluation of lower respiratory tract inflammation in chronic bronchitis by broncho-alveolar changes associated with local treatment with Immunytal, a biological response modifier. Chest 1994; 106: 19-26.
11. Eller J, Lapa E, Silva JR, Poulter LW, Lode H, Cole PJ. Cells and cytokines in chronic bronchial infection. In: Chignard M, Pretolani M, Renesto P, Vargaftig BB, (eds) Cells and cytokines in lung inflammation. Ann NY Acad Sci 1994; 725: 331-345.
12. Fietta A, Bersani C, De Rose V et al. Evaluation of systemic host defence mechanisms in chronic bronchitis. Respiration 1988; 53: 37-43.
13. Ruse GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-365.
14. Lomas DA, Chambra A, Ip M, Stockley RA. The effects of dexamethasone on human neutrophil functions in vitro and in vivo. Agents Actions 1991; 33: 279-285.
15. Llewellyn-Jones CG, Hill SL, Stockley RA. Effects of fluticasone propionate on neutrophil chemotaxis, superoxide generation and extracellular proteolytic activity in vitro. Thorax 1994; 49: 207-212.
16. Hand WL, Hand DL, King-Thompson NL. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1990; 34: 863-870.
17. Ottonello L, Morone P, Dapino P, Dallegri F. Inhibitory effect of salmeterol on the respiratory burst of adherent neutrophils. Clin Exp Immunol 1996; 106: 97-102.
18. 2-adrenoreceptor agonists: a new perspective in the treatment of asthma. Eur Respir J 1991; 4: 218-226.
19. Mita H, Shida T. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue. Allergy 1983; 38: 547-553.
20. Burns AM, Keogan M, Domaldson M, Brown DL, Park GR. Effects of inotropes on human leukocyte numbers, neutrophil function and lymphocyte subtypes. Br J Anaesthesiol 1997; 78: 530-535.
21. Gartner I. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 1980; 40: 133-136.
22. 2-adrenoceptor agonist. J Asthma 1998; 35: 401-408.
23. Lantero S, Alessandri G, Spallarossa D, Scraso L, Rossi GA. LFA-1 expression by blood eosinophils is increased in atopic asthmatic children and is involved in eosinophil locomotion. Eur Respir J 1998; 12: 1094-1098.
24. Muirhead KA, Schmitt TC, Muirhead AR. Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. Cytometry 1983; 3: 251-256.
25. Oddera S, Silvestri M, Sacco O, Eftimiadi C, Rossi GA. N-acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing. J Lab Clin Med 1994; 124: 293-301.
26. Tonetti M, Cavallero A, Botta GA, Niederman R, Eftimiadi C. Intracellular pH regulates the production of different oxigen metabolites in neutrophils: effects of organic acids produced by anaerobic bacteria. J Leukocyte Biol 1991; 49: 180-188.
27. Barnes BJ. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152: 828-860.
28. 2-agonists and methylxantines on neutrophil function in vitro. Eur Respir J 1994; 7: 1460-1466.
29. Rivkin I, Rosenblatt J, Becker EL. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the evaluation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J Immunol 1975; 115: 1126-1134.
30. Derian CK, Santulli RJ, Rao PE, Solomon HF, Barrett JA. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol 1995; 154: 308-317.
31. Oddera S, Silvestri M, Scarso L, Testi R, Rossi GA. Salmeterol inhibits the allergen-induced mononuclear cell proliferation and downregulates GM-CSF release and HLA-DR expression by monocytes. Pulm Pharmacol 1997; 10: 43-49.
32. Nielson CP. β-Adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol 1987; 139: 2392-2397.
33. O'Donnel SR, Wanstall JC. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol of β-adrenoceptors in guinea-pig trachea. Eur J Pharmacol 1978; 47: 333-341.
34. Lipworth B, Grove A. Evaluation of partial β-receptor agonist activity. Br J Clin Pharmacol 1997; 43: 9-14.
35. Faurschou P, Dahl R, Jeffery P, Venge P, Egerod I. Comparison of the anti-inflammatory effects of fluticasone and salmeterol in asthma: a placebo controlled, double blind, cross-over study with bronchoscopy, bronchial methacholine provocation and lavage. Eur Respir J 1997; 10: 243S (Abstract P1555).
36. Newman SP, Miller AB, Lennard-Jones TR, Moren F, Clarke SW. Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935-941.
37. Newman SP. Therapeutic aerosols. In: Clarke SW, Pavia D (eds) Aerosols and the Lung in Clinical and Experimental Aspects. London: Butterworths, 1984; 197-224.
38. Kerrebijn KF. Beta agonists. In: Kaliner MA, Barnes PJ, Persson CGA, (eds) Asthma: Its Pathology and Treatment. New York, NY, Maercel Dekker Inc., 1991; 523-545.
39. Masclans JR, Barberà JA, MacNee W, Pavia J, Piera C, Lornena F, Chung KF, Roca J, Rodriguez-Roisin R. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am J Respir Crit Care Med 1996; 154: 529-532.
40. Boschetto P, Roberts NM, Rogers DF, Barnes PJ. Effects of antiasthma drugs on microvascular leakage in guinea pig airways. Am Rev Respir Dis 1989; 149: 416-421.
41. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1997; 10: 815-821.